查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609027

元基因组体定序市场：依产品/服务、工作流程、技术、应用划分 - 2025-2030 年全球预测

Metagenomic Sequencing Market by Product & Service, Workflow, Technology, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年元基因组体定序市值为21.5亿美元，预计2024年将达23.9亿美元，复合年增长率为12.43%，到2030年将达到48.9亿美元。

元基因组组定序是基因体学的突破性方法，可分析环境样本的遗传物质，无需培养即可对微生物群落进行全面研究。这种方法对于了解土壤、海洋和人类肠道微生物组等环境中的复杂微生物组至关重要。其应用涵盖各个领域，包括检测病原体爆发的临床诊断、评估土壤健康的农业以及清理污染物的生物修復活动。最终用途多种多样，包括製药业、环境机构、学术研究机构和医疗保健。定序技术的进步、人们对微生物组在健康中作用的认识的提高以及研发投资的增加推动了市场的开拓。新的商机出现在个人化医疗和农业领域，其中元基因组分析根据个人的微生物组组成提供量身定制的健康解决方案，而农业则提供可持续的作物管理解决方案。挑战包括高成本、资料分析的复杂性以及阻碍资料解释的参考资料资料库的局限性。透过生物资讯工具的创新、降低定序成本和加强跨产业合作来应对这些挑战，有可能推动市场扩张。研究创新的关键部分包括开发更快、更具成本效益的定序技术和预测分析，以准确解释复杂的元基因组资料。该市场的特点是技术快速发展，并且随着公司努力提供差异化解决方案而竞争激烈。对于希望利用这一市场的公司的建议包括投资先进定序平台的研发、技术交流策略联盟以及全面的微生物组分析和解释服务，其中包括专注于扩大服务范围。总体而言，元基因组组定序在各个领域的整合凸显了其变革潜力，但市场参与企业必须克服挑战并利用永续成长的机会。

主要市场统计
基准年[2023] 21.5亿美元
预测年份 [2024] 23.9亿美元
预测年份 [2030] 48.9亿美元
复合年增长率（%） 12.43%

市场动态：揭示快速发展的元基因组定序市场的关键市场洞察

供需的动态交互作用正在改变元基因组组定序市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 评估细菌多样性和检测各种微生物的需求日益增加
    • 遗传疾病在世界各地的传播
    • 增加政府和私营部门对定序计划的投资
  • 市场限制因素
    • 定序资料的储存空间有限
    • 开发中国家最终用户的高价格
  • 市场机会
    • 元基因组序列资料管理的技术进步
    • 更好的元基因组组定序的技术开发
  • 市场问题
    • 缺乏技术精湛、经验丰富的人才

波特五力：驾驭元基因组定序市场的策略工具

波特的五力架构是了解元基因组体定序市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解元基因组体定序市场的外部影响

外部宏观环境因素在塑造元基因组定序市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解元基因组体定序市场的竞争格局

元基因组组定序市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵：元基因组定序市场供应商绩效评估

FPNV定位矩阵是评估元基因组定序市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製元基因组定序市场的成功之路

对于想要加强在全球市场的影响力的公司来说，元基因组定序市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 评估细菌多样性和检测各种微生物的需求日益增加
      • 世界各地遗传性疾病的发生率正在增加
      • 政府和私营部门增加对定序计划的投资
    • 抑制因素
      • 序列资料储存容量有限
      • 对于新兴国家的最终用户来说价格较高
    • 机会
      • 元基因组序列资料管理的技术进步
      • 更好的元基因组组定序的技术开发
    • 任务
      • 缺乏熟练且经验丰富的劳动力
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章元基因组体定序市场：依产品及服务分类

  • 介绍
  • 分析和资料解释解决方案
  • 装置
  • 试剂/耗材
  • 服务

第七章元基因组体定序市场：依工作流程

  • 介绍
  • 资料处理与分析
  • 样品处理和文库製备
  • 定序

第八章元基因组体定序市场：依技术分类

  • 介绍
  • 16S rRNA定序
  • 元转录组学
  • 鸟枪法宏基因组定序
  • 全基因测序与从头组装

第九章元基因组体定序市场：依应用分类

  • 介绍
  • 临床诊断
  • 药物发现
  • 生态学与环境应用
  • 工业用途
  • 土壤微生物组应用
  • 兽医应用

第十章美洲元基因组定序市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太宏元基因组定序市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲元基因组定序市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Azenta US, Inc.
  • BGI Genomics Co., Ltd.
  • CosmosID
  • DNASTAR, Inc.
  • Eurofins Genomics Germany GmbH
  • Freenome Holdings, Inc.
  • IntegraGen SA
  • Macrogen Europe BV
  • Microsynth AG
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Psomagen, Inc.
  • QIAGEN GmbH
Product Code: MRR-E3708867678B

The Metagenomic Sequencing Market was valued at USD 2.15 billion in 2023, expected to reach USD 2.39 billion in 2024, and is projected to grow at a CAGR of 12.43%, to USD 4.89 billion by 2030.

Metagenomic sequencing is a revolutionary approach in genomics that analyzes the genetic material from environmental samples, enabling the comprehensive study of microbial communities without the need for culturing. This approach is crucial for understanding complex microbiomes in environments such as soil, oceans, and human gut flora. Its applications span multiple fields, including clinical diagnostics, where it aids in detecting pathogen outbreaks, agriculture for soil health assessment, and bioremediation efforts to clean pollutants. The end-use scope extends across pharmaceutical industries, environmental agencies, academic research institutions, and healthcare. Market growth is driven by technological advancements in sequencing technologies, growing awareness about microbiomes' roles in health, and increased investment in research and development. Emerging opportunities lie in personalized medicine, where metagenomics can offer tailored health solutions based on individual microbiome compositions, and in agriculture, providing sustainable crop management solutions. Challenges include high costs, data analysis complexity, and limited reference databases, which can impede data interpretation. Addressing these challenges through innovation in bioinformatics tools, reducing sequencing costs, and enhancing cross-industry collaborations could facilitate market expansion. Key areas for research innovation include developing faster, more cost-effective sequencing technologies and predictive analytics to interpret complex metagenomic data accurately. The market is characterized by rapid technological evolution, leading to a highly competitive landscape as companies strive to offer differentiated solutions. Recommendations for businesses looking to capitalize on this market involve investing in R&D for advanced sequencing platforms, forming strategic alliances for technology exchange, and focusing on expanding service offerings to include comprehensive microbiome profiling and interpretation services. Overall, the integration of metagenomic sequencing in various sectors highlights its transformative potential, but market participants must navigate challenges and leverage opportunities for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.15 billion
Estimated Year [2024] USD 2.39 billion
Forecast Year [2030] USD 4.89 billion
CAGR (%) 12.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Metagenomic Sequencing Market

The Metagenomic Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising need for the evaluation of bacterial diversity and detection of various microbes
    • Growing prevalence of genetic disorders worldwide
    • Rising investment by government and private sector for sequencing projects
  • Market Restraints
    • Limited storage for the sequencing data
    • High price for the end-user in developing countries
  • Market Opportunities
    • Technological advancement for the metagenomic sequencing data management
    • Technological development for better metagenomic sequencing
  • Market Challenges
    • Dearth of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Metagenomic Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Metagenomic Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Metagenomic Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Metagenomic Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Metagenomic Sequencing Market

A detailed market share analysis in the Metagenomic Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Metagenomic Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Metagenomic Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Metagenomic Sequencing Market

A strategic analysis of the Metagenomic Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metagenomic Sequencing Market, highlighting leading vendors and their innovative profiles. These include Azenta US, Inc., BGI Genomics Co., Ltd., CosmosID, DNASTAR, Inc., Eurofins Genomics Germany GmbH, Freenome Holdings, Inc., IntegraGen S.A., Macrogen Europe BV, Microsynth AG, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer Inc., Psomagen, Inc., and QIAGEN GmbH.

Market Segmentation & Coverage

This research report categorizes the Metagenomic Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables, and Services.
  • Based on Workflow, market is studied across Data Processing & Analysis, Sample Processing & Library Preparation, and Sequencing.
  • Based on Technology, market is studied across 16S rRNA Sequencing, Metatranscriptomics, Shotgun Metagenomic Sequencing, and Whole-genome Sequencing & De Novo Assembly.
  • Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Ecological & Environmental Applications, Industrial applications, Soil Microbiome Applications, and Veterinary Applications.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for the evaluation of bacterial diversity and detection of various microbes
      • 5.1.1.2. Growing prevalence of genetic disorders worldwide
      • 5.1.1.3. Rising investment by government and private sector for sequencing projects
    • 5.1.2. Restraints
      • 5.1.2.1. Limited storage for the sequencing data
      • 5.1.2.2. High price for the end-user in developing countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement for the metagenomic sequencing data management
      • 5.1.3.2. Technological development for better metagenomic sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced workforce
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Metagenomic Sequencing Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Analysis & Data Interpretation Solutions
  • 6.3. Instruments
  • 6.4. Reagents & Consumables
  • 6.5. Services

7. Metagenomic Sequencing Market, by Workflow

  • 7.1. Introduction
  • 7.2. Data Processing & Analysis
  • 7.3. Sample Processing & Library Preparation
  • 7.4. Sequencing

8. Metagenomic Sequencing Market, by Technology

  • 8.1. Introduction
  • 8.2. 16S rRNA Sequencing
  • 8.3. Metatranscriptomics
  • 8.4. Shotgun Metagenomic Sequencing
  • 8.5. Whole-genome Sequencing & De Novo Assembly

9. Metagenomic Sequencing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery
  • 9.4. Ecological & Environmental Applications
  • 9.5. Industrial applications
  • 9.6. Soil Microbiome Applications
  • 9.7. Veterinary Applications

10. Americas Metagenomic Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Metagenomic Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Metagenomic Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Azenta US, Inc.
  • 2. BGI Genomics Co., Ltd.
  • 3. CosmosID
  • 4. DNASTAR, Inc.
  • 5. Eurofins Genomics Germany GmbH
  • 6. Freenome Holdings, Inc.
  • 7. IntegraGen S.A.
  • 8. Macrogen Europe BV
  • 9. Microsynth AG
  • 10. Novogene Co., Ltd.
  • 11. Oxford Nanopore Technologies PLC
  • 12. Pacific Biosciences of California, Inc.
  • 13. PerkinElmer Inc.
  • 14. Psomagen, Inc.
  • 15. QIAGEN GmbH

LIST OF FIGURES

  • FIGURE 1. METAGENOMIC SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. METAGENOMIC SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. METAGENOMIC SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. METAGENOMIC SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY DATA PROCESSING & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE PROCESSING & LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY METATRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SOIL MICROBIOME APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY VETERINARY APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023